Lecapon-Mepha 125 mg / 31.25 mg / 200 mg, Lactab - 30 Tablette(n) Swissmedic Key 65283007 Registration Holder Mepha Pharma AG Name Lecapon-Mepha 125 mg / 31.25 mg / 200 mg, Lactab Date of registration 25.03.2015 Introduction of Sequence 25.03.2015 ATC-Classification Levodopa, Decarboxylase Inhibitor and Comt Inhibitor (N04BA03) Revision date WHO WHO-DDD Valid until 31.07.2025 Index Therapeuticus (BSV) 01.08. Show package size 30 Tablette(n) Index Therapeuticus (Swissmedic) 01.08. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 19.36 Deductible k.A. Consumer price 37.45 Feedback FB Daily cost GTIN 7680652830076 Medication Code Synthetika Pharmacode 6294416 Disponibility
Composition levodopum 125.0 mg, carbidopum 31.25 mg, entacaponum 200.0 mg, cellulosum microcristallinum, lactosum 80.0 mg, hydroxypropylcellulosum substitutum humile, povidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: E 171, hypromellosum, glycerolum, E 172 (flavum), polysorbatum 80, E 172 (rubrum), magnesii stearas pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Carbidopa 31.25 mg Entacapone 200 mg Levodopa 125 mg
BAG: Active Agent Dose Carbidopa 31.25 mg Entacapone 200 mg Levodopa 125 mg
Inactive agents Dose additional_information Überzug color. Glycerol Hypromellosum 80 mg Polysorbatum 80 Povidone Silica Colloidalis Anhydrica
Source Data was imported : 04.12.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
